News

New York and California are reporting new virus variants that might be more contagious than the original strain.

Researchers at Estonia’s University of Tartu and France’s Paris-Saclay University are attempting to generate and utilize artificial genetic data. As opposed to simply artificially recreate cells and, ultimately, humans, the researchers are striving to better understand and encode the existing genetic diversity of people around the world.

The interview discusses the concern the pork industry has over the new variants of African Swine Fever which has killed over one billion pigs worldwide.

This article shows how Nigeria's investments in public health from previous disease outbreaks has helped it respond to the COVID 19 pandemic.

A recent study newly upgraded Anopheles stephensi genome. The study unearthed more than 3,000 genes that previously evaded scrutiny. The Anopheles stephensi is a major malaria vector mosquito in urban areas of South Asia and has recently been located in the horn of Africa.

Guinean health authorities have declared an outbreak of Ebola in a rural community in the south of the country, with at least seven people infected, two of whom died, the UN World Health Organization (WHO) confirmed.

A vaccine for use against the deadly Nipah and Hendra viruses has demonstrated effectiveness in preclinical studies as early as seven days following a single immunization, according to a new study, "A Single Dose Investigational Subunit Vaccine for Human Use against Nipah virus and Hendra virus," published in the journal, npj Vaccines, online February 8, 2021.

This article suggests yellow fever outbreaks can be stopped before they start by vaccinating monkeys who are hosts for yellow fever.

Astronauts aboard the International Space Station (ISS) are conducting experiments with an antimicrobial surface coating designed to fight the spread of bacteria and viruses. The coating was developed by The University of Queensland and Boeing as a joint research project to inhibit viral agents, such as the Earth-bound coronavirus responsible for the COVID-19 pandemic.

Efficient and cost-effective vaccine distribution remains one of the biggest challenges of 2021, so it’s no surprise that startup Notable Health wants to use their automation platform to help. Initially started to address the nearly $250 billion annual administrative costs in healthcare, Notable Health launched in 2017 to use automation to replace time-consuming and repetitive simple tasks in health industry admin. In early January of this year, they announced plans to use that technology as a way to help manage vaccine distribution.